These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7103519)

  • 21. Behçet's disease, palmoplantar pustulosis and HLA-B27 treatment with thalidomide.
    Hamza M
    Clin Exp Rheumatol; 1990; 8(4):427. PubMed ID: 2397633
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythema nodosum following thalidomide therapy for Behçet's disease.
    Viraben R; Dupré A
    Dermatologica; 1988; 176(2):107. PubMed ID: 3371520
    [No Abstract]   [Full Text] [Related]  

  • 23. Exacerbation of psoriasis by thalidomide in Behçet's syndrome.
    Dobson CM; Parslew RA
    Br J Dermatol; 2003 Aug; 149(2):432-3. PubMed ID: 12932265
    [No Abstract]   [Full Text] [Related]  

  • 24. The management of Behçet's syndrome: how are we doing?
    Yazici H; Yurdakul S; Hamuryudan V
    Clin Exp Rheumatol; 1999; 17(2):145-7. PubMed ID: 10342039
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of Behçet's syndrome in an African female patient with thalidomide.
    Lewis DA; Amerasinghe CN; Murphy SM
    Int J STD AIDS; 1996; 7(7):518-20. PubMed ID: 9116070
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behcet's disease therapy review].
    Vidaller Palacín A; Robert Olalla J; Sanuy Jiménez B; Rufi Rigau G; Folch Civit J; Charte González A
    An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide revisited.
    D'Arcy PF; Griffin JP
    Adverse Drug React Toxicol Rev; 1994; 13(2):65-76. PubMed ID: 7918899
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current use of thalidomide].
    Revuz J
    Ann Dermatol Venereol; 1990; 117(4):313-21. PubMed ID: 2195968
    [No Abstract]   [Full Text] [Related]  

  • 29. [An analysis of adverse drug reactions of thalidomide in treatment of immune-related bowel diseases].
    Luo HQ; Tan B; Lü H; Qian JM
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):726-9. PubMed ID: 24314159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide.
    Eisenbud L; Horowitz I; Kay B
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):289-92. PubMed ID: 3477744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Speculative ameloriation of arthritis in Behcet disease with thalidomide. A case report].
    Trèves R; Arnaud M; Jacob P; Lubeau M; Tabaraud F; Burki F; Desproges-Gotteron R
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):585. PubMed ID: 6533773
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment by thalidomide therapy of intestinal Behçet's disease associated with trisomy 8 myelodysplastic syndrome.
    Wei Q; Zhang X; Peng Y; Chen K; Xu S; Huang X; Zhang L; Xie Q; He Y; Li Y; Chai J
    Rheumatology (Oxford); 2021 Jun; 60(6):e200-e202. PubMed ID: 33331901
    [No Abstract]   [Full Text] [Related]  

  • 33. Thalidomide use.
    Am Fam Physician; 1983 Dec; 28(6):237. PubMed ID: 6650339
    [No Abstract]   [Full Text] [Related]  

  • 34. Thalidomide therapy for juvenile-onset entero-Behçet disease.
    Yasui K; Misawa Y; Shimizu T; Komiyama A; Kawakami T; Mizoguchi M
    J Pediatr; 2003 Nov; 143(5):692-4. PubMed ID: 14649666
    [No Abstract]   [Full Text] [Related]  

  • 35. Thalidomide: focus on its employment in rheumatologic diseases.
    Ossandon A; Cassarà EA; Priori R; Valesini G
    Clin Exp Rheumatol; 2002; 20(5):709-18. PubMed ID: 12412207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal involvement in children with Behçet's disease.
    Marchetti F; Trevisiol C; Ventura A
    Lancet; 2002 Jun; 359(9323):2115. PubMed ID: 12086789
    [No Abstract]   [Full Text] [Related]  

  • 37. Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis.
    Torras H; Lecha M; Mascaro JM
    Arch Dermatol; 1982 Nov; 118(11):875. PubMed ID: 7138037
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adamantiades-Behçet's disease. Clinical review].
    Störk S; Kneitz C; Bröcker EB; Hoyer C; Ertl G; Angermann CE
    Med Klin (Munich); 2008 Mar; 103(3):143-52. PubMed ID: 18344064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behçet's disease-like animal model.
    Sohn S; Lee ES; Lee SI; Kim YA; Kwon HJ; Bang D; Lee S
    Adv Exp Med Biol; 2003; 528():585-9. PubMed ID: 12918770
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
    Gardner-Medwin JM; Smith NJ; Powell RJ
    Ann Rheum Dis; 1994 Dec; 53(12):828-32. PubMed ID: 7864692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.